Consensus Keurig Dr Pepper Inc.

Equities

KDP

US49271V1008

Market Closed - Nasdaq Other stock markets 04:00:00 2023-12-04 pm EST			5-day change	1st Jan Change
32.23 ^USD	+0.19%		-0.98%	-9.62%

Nov. 30	More US retailers adopt 'keep it' returns policies to shelter profits in holiday surge	RE
Nov. 20	Wegovy craze was all the rage on Q3 earnings calls	RE

Evolution of the average Target Price on Keurig Dr Pepper Inc.

Price target over the last 5 years

History : Analyst Recommendations

0754bf.Jf40RFyCONUce92k_BBUHOhYSY_TrH8-jojAGX5VPQE.VpJ3C3HbabBVK4jXzkJiKtAvK-ak-jFh19mZaCksRTFfrUcROeRptGojnA~56aec03895cb119661bd93eb32223e48

Analyst Recommendations on Keurig Dr Pepper Inc.

ANALYST RECOMMENDATIONS : Airbnb, Apple, Best Buy, Diageo, Tesla...	Nov. 13
Barclays Raises Price Target on Keurig Dr Pepper to $36 From $34, Maintains Overweight Rating	Oct. 30	MT
UBS Cuts Keurig Dr Pepper Price Target to $37 From $39, Maintains Buy Rating	Oct. 27	MT
Morgan Stanley Cuts Price Target on Keurig Dr Pepper to $37 From $39, Maintains Overweight Rating	Oct. 27	MT
Deutsche Bank Trims Keurig Dr Pepper Price Target to $34 From $35, Maintains Hold Rating	Oct. 12	MT
Bernstein Adjusts Keurig Dr Pepper Price Target to $37 From $40, Maintains Outperform Rating	Oct. 12	MT
Citigroup Adjusts Price Target on Keurig Dr Pepper to $33 From $37, Maintains Neutral Rating	Oct. 11	MT
UBS Cuts Keurig Dr Pepper Price Target to $39 From $42, Maintains Buy Rating	Oct. 11	MT
ANALYST RECOMMENDATIONS : Apple, Progressive, Mondelez, Pepsico...	Sep. 13
UBS Upgrades Keurig Dr Pepper to Buy From Neutral, Adjusts Price Target to $42 From $37	Aug. 16	MT
Wedbush Raises Keurig Dr Pepper's Price Target to $40 From $37 After Higher-Than-Expected Q2 Results, Keeps Outperform Rating	Jul. 31	MT
Barclays Adjusts Price Target on Keurig Dr Pepper to $40 From $37, Maintains Overweight Rating	Jul. 28	MT
Goldman Sachs Trims Price Target on Keurig Dr Pepper to $34 From $35, Maintains Neutral Rating	Jul. 20	MT
Wedbush Adjusts Keurig Dr Pepper's PT to $37 From $40, Notes Likely Near-Term Overhang on Shares, Mounting Coffee Concerns; Keeps Outperform Rating	Jul. 11	MT
Citigroup Adjusts Price Target on Keurig Dr Pepper to $35 From $37, Maintains Neutral Rating	Jul. 11	MT
Keurig Dr Pepper Upgraded by Morgan Stanley to Overweight From Equalweight, Price Target Kept at $36, Firm Sees 'Opportune Entry Point'	Jul. 06	MT
Barclays Adjusts Price Target on Keurig Dr Pepper to $37 From $42, Keeps Overweight Rating	May. 01	MT
UBS Adjusts Keurig Dr Pepper Price Target to $37 From $39, Maintains Neutral Rating	Apr. 28	MT
Deutsche Bank Adjusts Keurig Dr Pepper Price Target to $35 From $36, Maintains Hold Rating	Apr. 28	MT
Barclays Adjusts Price Target on Keurig Dr Pepper to $37 From $42, Maintains Overweight Rating	Apr. 28	MT
Wedbush Lowers Keurig Dr Pepper's PT to $40 From $43, Notes Mounting Coffee Concerns, Likely Near-Term Overhang on Shares; Keeps Outperform Rating	Apr. 28	MT
JPMorgan Raises Keurig Dr Pepper's Price Target to $41 From $40, Maintains Overweight Rating	Apr. 18	MT
Barclays Raises Price Target on Keurig Dr Pepper to $42 From $40, Keeps Overweight Rating	Apr. 14	MT
Deutsche Bank Adjusts Keurig Dr Pepper Price Target to $36 From $38, Maintains Hold Rating	Mar. 20	MT
Barclays Adjusts Price Target on Keurig Dr Pepper to $40 From $45, Maintains Overweight Rating	Feb. 27	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

32.23USD

Average target price

35.82USD

Spread / Average Target

+11.14%

High Price Target

42USD

Spread / Highest target

+30.31%

Low Price Target

27USD

Spread / Lowest Target

-16.23%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Keurig Dr Pepper Inc.

Barclays
UBS
Morgan Stanley
Deutsche Bank Securities
Bernstein
Citigroup
Wedbush
Goldman Sachs
JPMorgan Chase
Credit Suisse
Wells Fargo Securities
Truist Securities
Jefferies & Co.
Consumer Edge
Guggenheim
RBC Capital Markets
Cowen
J.P. Morgan Chase

Ratings for Keurig Dr Pepper Inc.

Trading Rating :

Investor Rating :

ESG Refinitiv :

B+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar